Personalized blood thinners could cut stroke risk
NCT ID NCT06269432
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a blood test to guide antiplatelet medication can reduce the risk of a second stroke. People who have had a non-cardioembolic ischemic stroke and are already taking aspirin will be assigned to either continue standard aspirin or switch to a different antiplatelet drug based on their test results. The goal is to see if personalized treatment lowers the rate of blood clot-related events within 30 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
aspirin, clopidogrel, ticagrelor
What this could lead to
If successful, this approach could help doctors choose the right antiplatelet drug for each stroke patient, potentially lowering the chance of another stroke or heart attack.
What could go wrong
This is a single trial with 1,224 participants, and results may not apply to all stroke patients. There is also a risk of bleeding with antiplatelet drugs, which the study will monitor.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610072, China